This site uses cookies to ensure the best viewing experience for our readers.
Read more about it Got It

Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering

0 Comment Add Comment Add Comment

Post comment Cancel
Got it! We'll post your comment